Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

PE takeout frees up LSP’s team, promises bigger funds

Deal comes on back of raising Europe’s largest life sciences fund LSP 7 with first close at near $1 billion

November 10, 2021 8:29 PM UTC

Europe’s largest life sciences VC is set to get even bigger. On the back of raising nearly $1 billion for its seventh fund, LSP is being acquired by private equity firm EQT, setting up the VC to raise even larger funds in the future and freeing up partners to focus on their deals and portfolio companies.

Last week, LSP announced the first close of LSP 7 at €850 million ($982.9 million), making it the largest European life sciences VC fund to date. It’s the second consecutive LSP vehicle to hold that mantle, after LSP 6 closed in 2020 at €550 million...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article